Issue 22, 2013

Mesoporous silicananoparticle-based cisplatin prodrug delivery and anticancer effect under reductive cellular environment

Abstract

This work demonstrates the judicious application of a prodrug delivery strategy to achieve a highly improved anticancer drug effect of cisplatin using mesoporous silica nanoparticles. Our effort primarily addressed several pressing needs to overcome various impediments such as toxicity concerns, rapid inactivation, and low drug efficiency of cisplatin prodrug. The developed delivery system utilizes fluorescent mesoporous silica nanoparticles as a template to host the cisplatin prodrug through a reducible linkage. The inactive oxidized Pt(IV) complex installed on the surface of the mesoporous silica nanoparticles in the prodrug conferred stability to cisplatin; however, in the reductive environment of cancer cell lines the active cisplatin form was regenerated. Prodrug-conjugated nanoparticles showed 63 times lower IC50 value than that of cisplatin in HeLa cell line. The delivery system not only demonstrates enhanced cellular uptake but also shows a high drug effect which should diminish the associated side effects. Furthermore, a new, easy and inexpensive fluorescent based Pt quantification method has been adopted instead of the commonly used ICP-based quantification method and this strategy of quantification could be elaborated to monitor fluorescent prodrug nanoparticles during real-time diagnosis.

Graphical abstract: Mesoporous silica nanoparticle-based cisplatin prodrug delivery and anticancer effect under reductive cellular environment

Supplementary files

Article information

Article type
Paper
Submitted
07 Mar 2013
Accepted
03 Apr 2013
First published
04 Apr 2013

J. Mater. Chem. B, 2013,1, 2829-2836

Mesoporous silica nanoparticle-based cisplatin prodrug delivery and anticancer effect under reductive cellular environment

B. Ahn, J. Park, K. Singha, H. Park and W. J. Kim, J. Mater. Chem. B, 2013, 1, 2829 DOI: 10.1039/C3TB20319K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements